Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04551534 · ClinicalTrials.gov registry record · Phase 1
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DNL201 in Healthy Volunteers
A Phase 1 study, sponsored by Denali Therapeutics.
- Completed
- Registry status
- Phase 1
- Development phase
- 122
- Enrollment target
NCT04551534 is a Phase 1 study that has completed, run by Denali Therapeutics. The registered enrollment target is 122 participants.
The verdict
NCT04551534, a Phase 1 study, has completed, sponsored by Denali Therapeutics.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 122 participants
- Enrollment target
Study Summary
This is a Phase 1, randomized, double-blind, placebo-controlled, single- and multiple-ascending oral dose study conducted in three parts.
Interventions
- DRUG Placebo
- DRUG DNL201
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 122 participants |
| Start Date | 2017-06-01 |
| Est. Completion | 2018-08-08 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04551534
The ClinicalTrials.gov registry entry for NCT04551534 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 122 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Denali Therapeutics, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT04551534 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04551534 about?
NCT04551534 is a clinical study titled "A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DNL201 in Healthy Volunteers". This is a Phase 1, randomized, double-blind, placebo-controlled, single- and multiple-ascending oral dose study conducted in three parts.
What is the current status of trial NCT04551534?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 122 participants. The study started on 2017-06-01. Estimated completion is 2018-08-08.
What interventions are being tested in trial NCT04551534?
The interventions under investigation include: Placebo (DRUG), DNL201 (DRUG).
Who is sponsoring clinical trial NCT04551534?
This trial is sponsored by Denali Therapeutics, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.